Insider Transactions in Q4 2021 at Pear Therapeutics, Inc. (PEAR)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price | 
|---|---|---|---|---|---|
| 
            Dec 03                          
            2021                          
           | Yuri Maricich Chief Medical Officer | 
              BUY
             
                Grant, award, or other acquisition
             | Direct | 
              73,620
              +50.0%
           | 
              -                 
           | 
| 
            Dec 03                          
            2021                          
           | Corey Mc Cann President and CEO | 
              BUY
             
                Grant, award, or other acquisition
             | Indirect | 
              2,672,430
              +50.0%
           | 
              -                 
           | 
| 
            Dec 03                          
            2021                          
           | Corey Mc Cann President and CEO | 
              BUY
             
                Grant, award, or other acquisition
             | Direct | 
              8,157,656
              +50.0%
           | 
              -                 
           | 
| 
            Dec 03                          
            2021                          
           | Zack Lynch Director | 
              BUY
             
                Grant, award, or other acquisition
             | Indirect | 
              10,766,587
              +33.37%
           | 
              $107,665,870              
              $10.0 P/Share              
           | 
| 
            Dec 03                          
            2021                          
           | Andrew J. Schwab Director | 
              BUY
             
                Grant, award, or other acquisition
             | Indirect | 
              18,631,771
              +38.9%
           | 
              $186,317,710              
              $10.0 P/Share              
           | 
| 
            Dec 03                          
            2021                          
           | Lj10 LLC > 10% Shareholder | 
              BUY
             
                Conversion of derivative security
             | Direct | 
              6,540,000
              +50.0%
           | 
              -                 
           |